MCIM
ABMD

Meadow Creek Investment Management’s Abiomed Inc ABMD Stock Holding History

Meadow Creek Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$687K Buy
3,864
+784
+25% +$169K 0.01% 595
2019
Q2 		$802K Buy
3,080
+168
+6% +$44.6K 0.02% 552
2019
Q1 		$831K Buy
2,912
+336
+13% +$112K 0.02% 524
2018
Q4 		$837K Sell
2,576
-224
-8% -$77.8K 0.02% 471
2018
Q3 		$1.26M Sell
2,800
-6,832
-71% -$2.69M 0.02% 404
2018
Q2 		$3.94M Buy
9,632
+1,204
+14% +$436K 0.08% 226
2018
Q1 		$2.45M Buy
8,428
+392
+5% +$99.3K 0.05% 268
2017
Q4 		$1.51M Buy
8,036
+2,716
+51% +$507K 0.03% 361
2017
Q3 		$897K Buy
5,320
+560
+12% +$84.7K 0.02% 440
2017
Q2 		$682K Buy
4,760
+1,960
+70% +$263K 0.02% 509
2017
Q1 		$351K Sell
2,800
-616
-18% -$71.4K 0.01% 634
2016
Q4 		$385K Buy
+3,416
New +$396K 0.01% 583

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Meadow Creek Investment Management's ABMD Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Abiomed Inc (ABMD) stake by 25% in Q3 2019, buying an estimated $169K and bringing the position to 3,864 shares worth $687K. The position accounts for 0.01% of the portfolio, ranked #595.

Meadow Creek Investment Management first reported a position in ABMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.94M in Q2 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Meadow Creek Investment Management held 3,864 shares of Abiomed Inc worth $687K as of Q3 2019.
  • Meadow Creek Investment Management bought 784 Abiomed Inc shares in Q3 2019, an estimated $169K.
  • Abiomed Inc made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #595 holding.
  • Meadow Creek Investment Management first reported a position in Abiomed Inc in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Abiomed Inc position peaked at $3.94M in Q2 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.